CFD
XERS icon

Creative Financial Designs’s Xeris Biopharma Holdings XERS Stock Holding History

Creative Financial Designs’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Hold
2,200
– – ﹤0.01% 1339
2025
Q4 		$17.3K Hold
2,200
– – ﹤0.01% 1196
2025
Q3 		$17.9K Buy
2,200
+300
+16% +$1.99K ﹤0.01% 1178
2025
Q2 		$8.87K Sell
1,900
-155
-8% -$710 ﹤0.01% 1378
2025
Q1 		$11.3K Hold
2,055
– – ﹤0.01% 1262
2024
Q4 		$6.97K Hold
2,055
– – ﹤0.01% 1346
2024
Q3 		$5.86K Hold
2,055
– – ﹤0.01% 1334
2024
Q2 		$4.62K Hold
2,055
– – ﹤0.01% 1328
2024
Q1 		$4.54K Hold
2,055
– – ﹤0.01% 1328
2023
Q4 		$4.83K Buy
+2,055
New +$3.79K ﹤0.01% 1268

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Financial Designs's XERS Position: Q1 2026 in Review

Creative Financial Designs held its Xeris Biopharma Holdings (XERS) position steady in Q1 2026 at 2,200 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Creative Financial Designs first reported a position in XERS in Q4 2023 and has held it in 10 quarters since. The position peaked at $17.9K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Creative Financial Designs held 2,200 shares of Xeris Biopharma Holdings worth $12.8K as of Q1 2026.
  • Creative Financial Designs left its Xeris Biopharma Holdings share count unchanged in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1339 holding.
  • Creative Financial Designs first reported a position in Xeris Biopharma Holdings in Q4 2023 and has held it in 10 quarters since.
  • Creative Financial Designs's Xeris Biopharma Holdings position peaked at $17.9K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.